| Date | Name | Title | Action | No Shares | Price Per Share |
|---|---|---|---|---|---|
Insider Transactions For DYN | |||||
| 2025-07-16 | Friedl-naderer, Johanna | Chief Commercial Officer | Purchased | 51255 | $0.00 |
| 2025-07-16 | Cox, John | Director, CEO & President | Purchased | 197285 | $0.00 |
| 2025-07-16 | Kerr, Douglas | Chief Medical Officer | Purchased | 65110 | $0.00 |
| 2025-07-15 | Cox, John | Director, CEO & President | Sold | 10000 | $0.00 |
| 2025-07-14 | Cox, John | Director, CEO & President | Purchased | 100000 | $9.11 |
| 2025-06-05 | Friedl-naderer, Johanna | Chief Commercial Officer | Sold | 146 | $13.35 |
| 2025-06-05 | Kerr, Douglas | Chief Medical Officer | Sold | 1342 | $13.35 |
| 2025-06-05 | Cox, John | Director, CEO & President | Sold | 4060 | $13.35 |
| 2025-05-30 | Kersten, Dirk | Director | Purchased | 35000 | $0.00 |
| 2025-05-30 | Rhodes, Jason P | Director | Purchased | 35000 | $0.00 |
| 2025-05-30 | Stehman-breen, Catherine | Director | Purchased | 35000 | $0.00 |
| 2025-05-30 | Hurwitz, Edward | Director | Purchased | 35000 | $0.00 |
| 2025-05-30 | Lubner, David Charles | Director | Purchased | 35000 | $0.00 |
| 2025-05-30 | Incerti, Carlo | Director | Purchased | 35000 | $0.00 |
| 2025-03-31 | Lucera, Erick | Chief Financial Officer | Purchased | 66100 | $0.00 |
| 2025-03-31 | Lucera, Erick | Chief Financial Officer | Purchased | 214500 | $0.00 |
| 2025-03-13 | Friedl-naderer, Johanna | Chief Commercial Officer | Sold | 143 | $12.12 |
| 2025-03-11 | Beskrovnaya, Oxana | Chief Scientific Officer | Sold | 2153 | $11.38 |
| 2025-03-11 | Scalzo, Richard William | SVP, Head of Finance & Admin. | Sold | 1343 | $11.38 |
| 2025-03-05 | Cox, John | Director, CEO & President | Sold | 4061 | $11.83 |
